100 likes | 236 Views
Feasibility of establishing PVC in the Ugandan health system . By Juliet & Martin September 2004. Why monitor drugs. To document unknown Adverse Drug Reactions (ADR) and maximize safety
E N D
Feasibility of establishing PVC in the Ugandan health system By Juliet & Martin September 2004
Why monitor drugs • To document unknown Adverse Drug Reactions (ADR) and maximize safety • To encourage health professionals to share concerns about drugs – create an awareness of safety issues & drugs
What should be monitored? • All drugs, but priority to be given to ARVs, anti malarials, TB drugs.
Which reports to be investigated? • All suspected ADR but with special emphasis on unexpected ADRs and those that significantly affect compliance
Who monitors? • Health workers and care givers • The PV teams and MTC
How should monitoring occur? patients HW monitoring monitoring monitoring Regular reports Monitoring RPVC NPVC Less regular
When to encourage reporting events or reactions • 2 weeks to one month
How to manage non serious events • Sensitization of patients and health workers on frequent occurrences that may affect compliance
Resources available • HR can be mobilized • Financial resources are limited and needs mobilizing
Critical success factors • Adequate financial resources • Good communication • A good infrastructure (labs, equipment etc) • Well trained and sensitized health workers • Good will by all parties